Merck
  • 主页
  • 查找结果
  • Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.

Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine.

PloS one (2013-03-06)
Erlinda Fernández, Jorge R Toledo, Lídice Méndez, Nemecio González, Francisco Parra, José M Martín-Alonso, Miladys Limonta, Kosara Sánchez, Ania Cabrales, Mario P Estrada, Alina Rodríguez-Mallón, Omar Farnós
摘要

Recombinant virus-like particles (VLP) antigenically similar to rabbit hemorrhagic disease virus (RHDV) were recently expressed at high levels inside Pichia pastoris cells. Based on the potential of RHDV VLP as platform for diverse vaccination purposes we undertook the design, development and scale-up of a production process. Conformational and stability issues were addressed to improve process control and optimization. Analyses on the structure, morphology and antigenicity of these multimers were carried out at different pH values during cell disruption and purification by size-exclusion chromatography. Process steps and environmental stresses in which aggregation or conformational instability can be detected were included. These analyses revealed higher stability and recoveries of properly assembled high-purity capsids at acidic and neutral pH in phosphate buffer. The use of stabilizers during long-term storage in solution showed that sucrose, sorbitol, trehalose and glycerol acted as useful aggregation-reducing agents. The VLP emulsified in an oil-based adjuvant were subjected to accelerated thermal stress treatments. None to slight variations were detected in the stability of formulations and in the structure of recovered capsids. A comprehensive analysis on scale-up strategies was accomplished and a nine steps large-scale production process was established. VLP produced after chromatographic separation protected rabbits against a lethal challenge. The minimum protective dose was identified. Stabilized particles were ultimately assayed as carriers of a foreign viral epitope from another pathogen affecting a larger animal species. For that purpose, a linear protective B-cell epitope from Classical Swine Fever Virus (CSFV) E2 envelope protein was chemically coupled to RHDV VLP. Conjugates were able to present the E2 peptide fragment for immune recognition and significantly enhanced the peptide-specific antibody response in vaccinated pigs. Overall these results allowed establishing improved conditions regarding conformational stability and recovery of these multimers for their production at large-scale and potential use on different animal species or humans.

材料
货号
品牌
产品描述

Sigma-Aldrich
琼脂糖, BioReagent, for molecular biology, low EEO
Sigma-Aldrich
琼脂糖, Type I, low EEO
Sigma-Aldrich
琼脂糖, for molecular biology
Sigma-Aldrich
琼脂糖, Low EEO
Sigma-Aldrich
琼脂糖, Ultra-low Gelling Temperature, molecular biology grade
Sigma-Aldrich
琼脂糖, Medium EEO, for molecular biology
Sigma-Aldrich
Sepharose® 4B, 45-165 μm bead diameter
Sigma-Aldrich
琼脂糖, Type I-A, low EEO
Sigma-Aldrich
琼脂糖, Ultra-low Gelling Temperature
Sigma-Aldrich
琼脂糖, Low EEO, for Immunoelectrophoresis
Sigma-Aldrich
琼脂糖, Type II-A, Medium EEO
Sigma-Aldrich
琼脂糖, High Gelling Temperature
Sigma-Aldrich
琼脂糖, High EEO, for molecular biology
Sigma-Aldrich
Sepharose® 6B, 6% Beaded Agarose, 45-165 μm (wet), fractionation range 10,000-1,000,000 Da (dextrans)
Sigma-Aldrich
琼脂糖, Wide range, for molecular biology
Sigma-Aldrich
琼脂糖, High EEO
Sigma-Aldrich
琼脂糖, For pulsed field electrophoresis running gel
Sigma-Aldrich
琼脂糖, BioReagent, for molecular biology, Wide range/Standard 3:1
Sigma-Aldrich
琼脂糖, Special High EEO
Sigma-Aldrich
琼脂糖, Type IV, Special High EEO
Sigma-Aldrich
琼脂糖, Vetec, reagent grade